摘要
目的探讨肝动脉化疗无水乙醇栓塞术(transcatheter arteral ethanol-chemoembolization,TAECE)联合经皮穿刺无水乙醇注射(percutaneous ethanol injection,PEI)治疗大肝癌与TACE疗法的临床效果。方法 48例大肝癌行TAECE+PEI治疗,49例行肝动脉化疗栓塞术(transcatheter hepatic arteral chemoembolization,TACE)治疗。所有病例随访2年以上。结果 TAECE+PEI组1、2年累计生存率分别为78.4%和54.1%,TACE组则相应为59.2%和38.8%。结论对于大肝癌TAECE+PEI治疗1~2年生存率明显高于TACE,是较好的综合介入治疗方法。
Objective To discuss the clinical effectiveness of transcatheter arteral ethanol-chemoembolization(TAECE)combined with percutaneous ethanol injection(PEI)in the treatment of large hepatic cancers.Methods A totale of 48 patients with large hepatic cancers received TAECE combined with PEI,and the other 49 patients received only transcatheter hepatic arteral chemoembolization(TACE).Results In TAECE plus PEI Group,the 1-,2-year survival rate were78.4%,54.1%,and in TACE Group,the 1-,2-year survival rate were 59.2%,38.8%.Conclusion Transcatheter arteral ethanol-chemoembolization combined with percutaneous ethanol injection,as a treatment measure of large hepatic cancers,is safe,effective and practical.
出处
《医学影像学杂志》
2015年第8期1397-1399,1403,共4页
Journal of Medical Imaging
关键词
肝癌
无水乙醇
动脉化疗栓塞
Liver cancer
Ethanol
Transarterial chemoembolization